Drug Database
Back to search

United States· US:49252-008_3fb45d3e-3fbc-8814-e063-6294a90a4a70

duloxetine

A duloxetine product containing duloxetine hydrochloride, registered in United States by Inventia Healthcare Limited.. The same ATC class is registered in 16 of our 19 countries.

ATC N06AX21US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedduloxetineATCN06AX21REGISTER NO.US:49252-008_3fb45d3e…PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about duloxetine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Duloxetine is registered in 16 of 19 countries.

Countries holding a registration under ATC N06AX21 (duloxetine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search duloxetine products by name

Duloxetine · ATC N06AX21

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of duloxetine costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.28 in United States to $1.57 in Switzerland — a ×5.6 gap.

  • United States: $0.28 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Duloxetine · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.57
  • IT Italy$0.67
  • US United States$0.28 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DULOXETINE HYDROCHLORIDE
Manufacturer
Inventia Healthcare Limited.
Country
United States (US)
ATC code
N06AX21
ATC class
Duloxetine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 10

  • ndc11
    4925200810
    30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-10)
  • ndc11
    4925200811
    60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-11)
  • ndc11
    4925200812
    90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-12)
  • ndc11
    4925200818
    1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-18)
  • ndc11
    4925200857
    100 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (49252-008-57)
  • ndc11
    49252-008-10
  • ndc11
    49252-008-11
  • ndc11
    49252-008-12
  • ndc11
    49252-008-18
  • ndc11
    49252-008-57

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

501 interactions on record for duloxetine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check duloxetine against other medicinesHow interaction checks work

Duloxetine · interactions on record

501 records

  • 33 severe
  • 247 moderate
  • 23 minor
  • 130 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

68 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Duloxetine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All duloxetine products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Dulasolan, Duloxetin +pharma
  • Belgium · Duloxetin Ab, Duloxétine Ab
  • Bulgaria · Dulasolan, Duxet
  • Cyprus · Dulox, Duloxetine Accord
  • Czechia · Dolyxan, Dulasolan
  • Germany · Dulasolan, Duloxalta
  • Denmark · Aritavi, Duciltia
  • Estonia · Dulsevia, Onelar
  • Spain · Dedulox 30 Mg Cápsulas Duras Gastrorresistentes Efg, Dedulox 60 Mg
  • Finland · Duloxetin Stada, Duloxetine Accord
  • France · Duloxetine Accord, Duloxetine Almus
  • United Kingdom (Northern Ireland) · Depalta, Duciltia
  • Greece · Duciltia, Duloxetine Liconsa
  • Croatia · Dolyxan, Duloksetin Pliva
  • Hungary · Duciltia, Dulodet
  • Ireland · Duloxetine Accord, Duloxetine Clonmel
  • Iceland · Aritavi, Cymbalta
  • Italy · Alikres, Dulex
  • Liechtenstein · Cymbalta, Duloxetine Lilly
  • Lithuania · Dulsevia
  • Luxembourg · Duloxetin Ab, Duloxetine Liconsa
  • Latvia · Dulsevia
  • Malta · Onelar
  • Netherlands · Dulasolan, Dulodet
  • Norway · Cymbalta, Duloxetin Krka
  • Poland · Aurodulox, Depratal
  • Portugal · Duloxetina Alter, Duloxetina Amperlem
  • Romania · Dozzex, Duloxetină Dr. Reddy's
  • Sweden · Aritavi, Dulmis
  • Slovenia · Duloksetin Sandoz, Dulsevia
  • Slovakia · Duloxetin Krka, Duloxetin Krka, D.D., Novo Mesto

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f25b1bd8-d9da-4bac-a7ed-d1ae5f67904d
GET /v1/drugs/f25b1bd8-d9da-4bac-a7ed-d1ae5f67904d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "30",
  "substance": "DULOXETINE HYDROCHLORIDE",
  "productndc": "49252-008",
  "dosage_form": "CAPSULE, DELAYED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202336",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about duloxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console